ARTEMISMEDBSEArtemis Medicare Services LtdMinimalNeutral
Announced Mon, 25 May · 15:43 IST

Annual Secretarial Compliance Report for the year ended March 31, 2026

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.1%1-day move
₹288.50
prior close
₹288.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.0+0.3-0.3-4.1-5.4-7.6-5.7-7.4-5.9-8.3-8.8-3.5
Up moveDown movePending
AI summary

Artemis Medicare Services has filed its Annual Secretarial Compliance Report for FY2026, examined by DMK Associates, Practicing Company Secretaries. The report confirms full compliance with SEBI regulations including LODR, ICDR, SAST, SBEB, and PIT regulations. One prior observation from FY2025 was addressed — an investor meet scheduled for June 21, 2024 was intimated to exchanges with a one-day delay, for which BSE and NSE had issued cautionary emails. The company confirmed remedial actions including disseminating emails to stock exchanges and placing them before the Board. All 13 compliance checkpoints including secretarial standards, policy adoption, website maintenance, director disqualification checks, related party transactions, and insider trading compliance returned satisfactory status.

Likely market impact

The clean compliance report with no additional non-observations is a positive signal for shareholders, indicating strong corporate governance practices. No penalties or regulatory actions were taken against the company during FY2026.